Improving Bladder Cancer Detection with Blood Tests
Author Information
Author(s): Andrea Staack, Steffen Badendieck, Dietmar Schnorr, Stefan A Loening, Klaus Jung
Primary Institution: Department of Urology, University Hospital Charité, CCM, Humboldt University, Berlin, Germany
Hypothesis
The study aims to evaluate the diagnostic value of various circulating MMPs and TIMPs in blood plasma for non-invasive detection of transitional cell carcinoma of the bladder.
Conclusion
MMP2 is a significant marker in blood plasma for bladder cancer detection, especially when combined with MMP9 and TIMP1.
Supporting Evidence
- MMP2 concentration was significantly higher in TCC patients compared to controls.
- The combination of MMP9 and TIMP1 showed improved sensitivity and specificity.
- MMP2 alone had a sensitivity of 75%, which increased to 97% when combined with MMP9 and TIMP1.
Takeaway
Doctors can use blood tests to find bladder cancer more easily by looking at certain proteins in the blood.
Methodology
The study quantified MMPs and TIMPs in blood plasma using ELISA from patients with TCC and healthy controls.
Limitations
The study had a small number of patients and did not include patients with benign urological diseases.
Participant Demographics
68 patients with TCC (57 non-metastasized, 11 metastasized) and 79 healthy controls.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website